Cholecystokinin-Cholescintigraphy in Adults

Consensus Recommendations of an Interdisciplinary Panel

John K. DiBaise, Bryan K. Richmond, Harvey H. Ziessman, Gregory T. Everson, Robert D. Fanelli, Alan Maurer, Ann Ouyang, Peter Shamamian, Richard J. Simons, Laura A. Wall, Thomas J. Weida, Mark Tulchinsky

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background & Aims: Cholecystokinin-cholescintigraphy (CCK-CS) provides a physiologic, noninvasive, and quantitative method for assessing gallbladder contraction and calculation of a gallbladder ejection fraction (GBEF). At present, it is used most commonly to identify patients with suspected functional gallbladder disorder. However, the methodology of CCK infusion and normal values differ markedly among imaging centers. Methods: This document represents the consensus opinion of an interdisciplinary panel that gathered to assess the current optimal method for performing CCK-CS in adults, potential uses and limitations of CCK-CS, and questions that require further investigation. Results: The panel recommended the use of a single, standardized, recently described CCK-CS protocol that involves infusion of 0.02 μg/kg of sincalide over 60 minutes with a normal gallbladder ejection fraction defined as ≥38%. The panel emphasized the need for a large, multicenter, prospective clinical trial to establish the utility of CCK-CS in the diagnosis of functional gallbladder disease. Although not without controversy regarding its clinical utility, the primary indication for CCK-CS at present is the well-selected patient with suspected functional gallbladder disorder. Conclusions: Agreement was reached that the adoption of this standardized protocol is critical to improve how CCK-CS is used to direct patient care and will represent an improvement over the diverse methods currently in use by eliminating the current lack of uniformity and adding both reliability and credibility to the results.

Original languageEnglish (US)
Pages (from-to)376-384
Number of pages9
JournalClinical Gastroenterology and Hepatology
Volume9
Issue number5
DOIs
StatePublished - May 2011

Fingerprint

Cholecystokinin
Gallbladder
Gallbladder Diseases
Sincalide
Patient Care
Reference Values
Clinical Trials

Keywords

  • Cholecystokinin-cholescintigraphy
  • Functional Gallbladder Disorder
  • Gallbladder Ejection Fraction

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

DiBaise, J. K., Richmond, B. K., Ziessman, H. H., Everson, G. T., Fanelli, R. D., Maurer, A., ... Tulchinsky, M. (2011). Cholecystokinin-Cholescintigraphy in Adults: Consensus Recommendations of an Interdisciplinary Panel. Clinical Gastroenterology and Hepatology, 9(5), 376-384. https://doi.org/10.1016/j.cgh.2011.02.013

Cholecystokinin-Cholescintigraphy in Adults : Consensus Recommendations of an Interdisciplinary Panel. / DiBaise, John K.; Richmond, Bryan K.; Ziessman, Harvey H.; Everson, Gregory T.; Fanelli, Robert D.; Maurer, Alan; Ouyang, Ann; Shamamian, Peter; Simons, Richard J.; Wall, Laura A.; Weida, Thomas J.; Tulchinsky, Mark.

In: Clinical Gastroenterology and Hepatology, Vol. 9, No. 5, 05.2011, p. 376-384.

Research output: Contribution to journalArticle

DiBaise, JK, Richmond, BK, Ziessman, HH, Everson, GT, Fanelli, RD, Maurer, A, Ouyang, A, Shamamian, P, Simons, RJ, Wall, LA, Weida, TJ & Tulchinsky, M 2011, 'Cholecystokinin-Cholescintigraphy in Adults: Consensus Recommendations of an Interdisciplinary Panel', Clinical Gastroenterology and Hepatology, vol. 9, no. 5, pp. 376-384. https://doi.org/10.1016/j.cgh.2011.02.013
DiBaise, John K. ; Richmond, Bryan K. ; Ziessman, Harvey H. ; Everson, Gregory T. ; Fanelli, Robert D. ; Maurer, Alan ; Ouyang, Ann ; Shamamian, Peter ; Simons, Richard J. ; Wall, Laura A. ; Weida, Thomas J. ; Tulchinsky, Mark. / Cholecystokinin-Cholescintigraphy in Adults : Consensus Recommendations of an Interdisciplinary Panel. In: Clinical Gastroenterology and Hepatology. 2011 ; Vol. 9, No. 5. pp. 376-384.
@article{474f1722c1fb483494ae22226aa72d1f,
title = "Cholecystokinin-Cholescintigraphy in Adults: Consensus Recommendations of an Interdisciplinary Panel",
abstract = "Background & Aims: Cholecystokinin-cholescintigraphy (CCK-CS) provides a physiologic, noninvasive, and quantitative method for assessing gallbladder contraction and calculation of a gallbladder ejection fraction (GBEF). At present, it is used most commonly to identify patients with suspected functional gallbladder disorder. However, the methodology of CCK infusion and normal values differ markedly among imaging centers. Methods: This document represents the consensus opinion of an interdisciplinary panel that gathered to assess the current optimal method for performing CCK-CS in adults, potential uses and limitations of CCK-CS, and questions that require further investigation. Results: The panel recommended the use of a single, standardized, recently described CCK-CS protocol that involves infusion of 0.02 μg/kg of sincalide over 60 minutes with a normal gallbladder ejection fraction defined as ≥38{\%}. The panel emphasized the need for a large, multicenter, prospective clinical trial to establish the utility of CCK-CS in the diagnosis of functional gallbladder disease. Although not without controversy regarding its clinical utility, the primary indication for CCK-CS at present is the well-selected patient with suspected functional gallbladder disorder. Conclusions: Agreement was reached that the adoption of this standardized protocol is critical to improve how CCK-CS is used to direct patient care and will represent an improvement over the diverse methods currently in use by eliminating the current lack of uniformity and adding both reliability and credibility to the results.",
keywords = "Cholecystokinin-cholescintigraphy, Functional Gallbladder Disorder, Gallbladder Ejection Fraction",
author = "DiBaise, {John K.} and Richmond, {Bryan K.} and Ziessman, {Harvey H.} and Everson, {Gregory T.} and Fanelli, {Robert D.} and Alan Maurer and Ann Ouyang and Peter Shamamian and Simons, {Richard J.} and Wall, {Laura A.} and Weida, {Thomas J.} and Mark Tulchinsky",
year = "2011",
month = "5",
doi = "10.1016/j.cgh.2011.02.013",
language = "English (US)",
volume = "9",
pages = "376--384",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Cholecystokinin-Cholescintigraphy in Adults

T2 - Consensus Recommendations of an Interdisciplinary Panel

AU - DiBaise, John K.

AU - Richmond, Bryan K.

AU - Ziessman, Harvey H.

AU - Everson, Gregory T.

AU - Fanelli, Robert D.

AU - Maurer, Alan

AU - Ouyang, Ann

AU - Shamamian, Peter

AU - Simons, Richard J.

AU - Wall, Laura A.

AU - Weida, Thomas J.

AU - Tulchinsky, Mark

PY - 2011/5

Y1 - 2011/5

N2 - Background & Aims: Cholecystokinin-cholescintigraphy (CCK-CS) provides a physiologic, noninvasive, and quantitative method for assessing gallbladder contraction and calculation of a gallbladder ejection fraction (GBEF). At present, it is used most commonly to identify patients with suspected functional gallbladder disorder. However, the methodology of CCK infusion and normal values differ markedly among imaging centers. Methods: This document represents the consensus opinion of an interdisciplinary panel that gathered to assess the current optimal method for performing CCK-CS in adults, potential uses and limitations of CCK-CS, and questions that require further investigation. Results: The panel recommended the use of a single, standardized, recently described CCK-CS protocol that involves infusion of 0.02 μg/kg of sincalide over 60 minutes with a normal gallbladder ejection fraction defined as ≥38%. The panel emphasized the need for a large, multicenter, prospective clinical trial to establish the utility of CCK-CS in the diagnosis of functional gallbladder disease. Although not without controversy regarding its clinical utility, the primary indication for CCK-CS at present is the well-selected patient with suspected functional gallbladder disorder. Conclusions: Agreement was reached that the adoption of this standardized protocol is critical to improve how CCK-CS is used to direct patient care and will represent an improvement over the diverse methods currently in use by eliminating the current lack of uniformity and adding both reliability and credibility to the results.

AB - Background & Aims: Cholecystokinin-cholescintigraphy (CCK-CS) provides a physiologic, noninvasive, and quantitative method for assessing gallbladder contraction and calculation of a gallbladder ejection fraction (GBEF). At present, it is used most commonly to identify patients with suspected functional gallbladder disorder. However, the methodology of CCK infusion and normal values differ markedly among imaging centers. Methods: This document represents the consensus opinion of an interdisciplinary panel that gathered to assess the current optimal method for performing CCK-CS in adults, potential uses and limitations of CCK-CS, and questions that require further investigation. Results: The panel recommended the use of a single, standardized, recently described CCK-CS protocol that involves infusion of 0.02 μg/kg of sincalide over 60 minutes with a normal gallbladder ejection fraction defined as ≥38%. The panel emphasized the need for a large, multicenter, prospective clinical trial to establish the utility of CCK-CS in the diagnosis of functional gallbladder disease. Although not without controversy regarding its clinical utility, the primary indication for CCK-CS at present is the well-selected patient with suspected functional gallbladder disorder. Conclusions: Agreement was reached that the adoption of this standardized protocol is critical to improve how CCK-CS is used to direct patient care and will represent an improvement over the diverse methods currently in use by eliminating the current lack of uniformity and adding both reliability and credibility to the results.

KW - Cholecystokinin-cholescintigraphy

KW - Functional Gallbladder Disorder

KW - Gallbladder Ejection Fraction

UR - http://www.scopus.com/inward/record.url?scp=79955001990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955001990&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2011.02.013

DO - 10.1016/j.cgh.2011.02.013

M3 - Article

VL - 9

SP - 376

EP - 384

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 5

ER -